Loading
Latest filing published 10 Feb 2017 for Sophiris Bio Inc..
No signal scores available.
James Leslie Heppell discloses dealings in Sophiris Bio Inc. to SEDI. We count 8 filings; the first trade dates from 9 August 2013 and the latest from 27 October 2016.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 10 February 2017, reports a transaction in Sophiris Bio Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations